MedPath

Magnesium aspartate

Generic Name
Magnesium aspartate
Drug Type
Small Molecule
Chemical Formula
C8H20MgN2O12
CAS Number
7018-07-7
Unique Ingredient Identifier
R17X820ROL

Overview

Magnesium aspartate is a magnesium salt of aspartic acid that is commonly used as a mineral supplement. It displays high oral bioavailability and water solubiltiy compared to other magnesium salts such as magnesium citrate, magnesium carbonate and magnesium oxide.

Indication

No indication information available.

Associated Conditions

  • Arrhythmia
  • Combined magnesium and potassium deficiency
  • Magnesium Deficiency
  • Potassium deficiency

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
Swisse Ultiboost Daily Immune Support
326213
Medicine
A
11/13/2019
Kids Multi
329564
Medicine
A
2/6/2020
Magnesium Advanced
300608
Medicine
A
3/9/2018
Ultimate Mag
389412
Medicine
A
6/2/2022
Super Magnesium Powder
324369
Medicine
A
10/2/2019
Health Right Australia Magnesium
346877
Medicine
A
10/30/2020
Magnesium Advanced
407751
Medicine
A
4/17/2023
Advanced Medicine Hepatic Detox
95172
Advanced Medicine Australia Pty Ltd
Medicine
A
6/24/2003
EAGLE POTASI TABLETS
370214
Medicine
A
6/25/2021
NZ Swisse Women's Ultivite 50+
324281
Medicine
A
9/30/2019

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
M COM NO 2 A
thorne research canada ltd.
00615641
Capsule - Oral
75 MG / TAB
12/31/1984
LSP
seroyal international inc.
00567396
Tablet - Oral
50 MG
12/31/1982
M COM NO 1 A
thorne research canada ltd.
00615633
Capsule - Oral
90 MG / TAB
12/31/1984

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.